JP Morgan Chase’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,061
| Closed | -$194 | – | 7880 |
|
|
2025
Q1 | $194 | Sell |
2,061
-3
| -0.1% | -$1 | ﹤0.01% | 6804 |
|
|
2024
Q4 | $1.45K | Sell |
2,064
-1
| -0% | -$1 | ﹤0.01% | 6683 |
|
|
2024
Q3 | $1.67K | Sell |
2,065
-14
| -0.7% | -$16 | ﹤0.01% | 6644 |
|
|
2024
Q2 | $3.1K | Buy |
2,079
+2
| +0.1% | +$5 | ﹤0.01% | 6459 |
|
|
2024
Q1 | $6.44K | Buy |
2,077
+3
| +0.1% | +$13 | ﹤0.01% | 6404 |
|
|
2023
Q4 | $8.46K | Buy |
2,074
+4
| +0.2% | +$16 | ﹤0.01% | 6446 |
|
|
2023
Q3 | $11.1K | Buy |
2,070
+6
| +0.3% | +$23 | ﹤0.01% | 6229 |
|
|
2023
Q2 | $6.83K | Buy |
2,064
+24
| +1% | +$101 | ﹤0.01% | 6114 |
|
|
2023
Q1 | $11K | Hold |
2,040
| – | – | ﹤0.01% | 6107 |
|
|
2022
Q4 | $10K | Hold |
2,040
| – | – | ﹤0.01% | 6040 |
|
|
2022
Q3 | $11K | Hold |
2,040
| – | – | ﹤0.01% | 5949 |
|
|
2022
Q2 | $18K | Sell |
2,040
-2,283
| -53% | -$23.2K | ﹤0.01% | 5923 |
|
|
2022
Q1 | $67K | Buy |
4,323
+2,413
| +126% | +$41.8K | ﹤0.01% | 5682 |
|
|
2021
Q4 | $50K | Buy |
1,910
+5
| +0.3% | +$190 | ﹤0.01% | 5948 |
|
|
2021
Q3 | $93K | Buy |
1,905
+11
| +0.6% | +$680 | ﹤0.01% | 5606 |
|
|
2021
Q2 | $160K | Sell |
1,894
-252
| -12% | -$21.6K | ﹤0.01% | 5343 |
|
|
2021
Q1 | $218K | Sell |
2,146
-194
| -8% | -$21.3K | ﹤0.01% | 5117 |
|
|
2020
Q4 | $235K | Buy |
2,340
+370
| +19% | +$24.7K | ﹤0.01% | 4756 |
|
|
2020
Q3 | $96K | Buy |
1,970
+913
| +86% | +$46.9K | ﹤0.01% | 4712 |
|
|
2020
Q2 | $61K | Buy |
+1,057
| New | +$70.6K | ﹤0.01% | 4766 |
|
Other funds holding AWH
JP Morgan Chase's AWH Position: Q2 2025 in Review
JP Morgan Chase sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q2 2025, closing a stake of 2,061 shares — an estimated $194 sold.
JP Morgan Chase first reported a position in AWH in Q2 2020 and held it in 20 quarters. The position peaked at $235K in Q4 2020. 2 funds tracked by Wall St. Rank hold AWH as of Q2 2025.
- JP Morgan Chase reported no remaining Aspira Women's Health Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
- JP Morgan Chase sold 2,061 Aspira Women's Health Inc. Common Stock shares in Q2 2025, an estimated $194.
- JP Morgan Chase first reported a position in Aspira Women's Health Inc. Common Stock in Q2 2020 and held it in 20 quarters.
- JP Morgan Chase's Aspira Women's Health Inc. Common Stock position peaked at $235K in Q4 2020.
- 2 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q2 2025.
Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.